相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases
Karen L. DeBalsi et al.
AGEING RESEARCH REVIEWS (2017)
Cytoprotective Effects of a Novel Nrf2 Activator, RS9, in Rhodopsin Pro347Leu Rabbits
Yasuhiro Nakagami et al.
CURRENT EYE RESEARCH (2016)
Dimethyl Fumarate: A Review in Relapsing-Remitting MS
Emma D. Deeks
DRUGS (2016)
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Meng-Chen Lu et al.
MEDICINAL RESEARCH REVIEWS (2016)
Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?
Christine A. Houghton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
siRNA-Mediated Knockdown of the mTOR Inhibitor RTP801 Promotes Retinal Ganglion Cell Survival and Axon Elongation by Direct and Indirect Mechanisms
Peter J. Morgan-Warren et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Dissecting molecular cross-talk between Nrf2 and NF-kappa B response pathways
Joanna D. Wardyn et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
Geoff Wells
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits
Yasuhiro Nakagami et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function The AREDS2 Randomized Clinical Trial
Emily Y. Chew et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery
Hsin-Hui Shen et al.
NANOMEDICINE (2015)
Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents
Dhulfiqar Ali Abed et al.
ACTA PHARMACEUTICA SINICA B (2015)
Diabetic retinopathy - Biomolecules and multiple pathophysiology
Haseeb Ahsan
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
Melanie P. Chin et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
New strategies to inhibit KEAP1 and the CuI3-based E3 ubiquitin ligases
Peter Canning et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
NRF2 plays a protective role in diabetic retinopathy in mice
Zhenhua Xu et al.
DIABETOLOGIA (2014)
Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
Elisabeth C. R. Solano et al.
NUCLEIC ACID THERAPEUTICS (2014)
Damage of photoreceptor-derived cells in culture induced by light emitting diode-derived blue light
Yoshiki Kuse et al.
SCIENTIFIC REPORTS (2014)
The Role of Ultraviolet Radiation in the Ocular System of Mammals
Mercede Majdi et al.
PHOTONICS (2014)
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction
Longqin Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death
Noriko Himori et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Synthetic oleanane triterpenoids: magic bullets or not?
Hanna E. Abboud
KIDNEY INTERNATIONAL (2013)
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
Stacey Ruiz et al.
KIDNEY INTERNATIONAL (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Toward clinical application of the Keap1-Nrf2 pathway
Takafumi Suzuki et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis-Related Fibrosis in a Dietary Rat Model
Rieko Shimozono et al.
MOLECULAR PHARMACOLOGY (2013)
Transcription Factor Nrf2-Mediated Antioxidant Defense System in the Development of Diabetic Retinopathy
Qing Zhong et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Therapeutic stratagems for vascular degenerative disorders of the posterior eye
Gaurav K. Jain et al.
DRUG DISCOVERY TODAY (2012)
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Kai Takaya et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
How does the macula protect itself from oxidative stress?
James T. Handa
MOLECULAR ASPECTS OF MEDICINE (2012)
Consequences of oxidative stress in age-related macular degeneration
Stuart G. Jarrett et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
Ultraviolet Phototoxicity to the Retina
Randolph D. Glickman
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2011)
Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury
Yanhong Wei et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Age-Related Retinopathy in NRF2-Deficient Mice
Zhenyang Zhao et al.
PLOS ONE (2011)
New Concept in Nutrition for the Maintenance of the Aging Eye Redox Regulation and Therapeutic Treatment of Cataract Disease; Synergism of Natural Antioxidant Imidazole-Containing Amino Acid-Based Compounds, Chaperone, and Glutathione Boosting Agents: A Systemic Perspective on Aging and Longevity Emerged From Studies in Humans
Mark A. Babizhayev
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
Ken Itoh et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Clinical Trial of Lutein in Patients With Retinitis Pigmentosa Receiving Vitamin A
Eliot L. Berson et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Biodegradable Intraocular Therapies for Retinal Disorders Progress to Date
Noriyuki Kuno et al.
DRUGS & AGING (2010)
Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy
Koichi Uno et al.
EXPERIMENTAL EYE RESEARCH (2010)
Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration
Marisol Cano et al.
VISION RESEARCH (2010)
Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial
Wai T. Wong et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Nrf2 is a critical modulator of the innate immune response in a model of uveitis
Norihiro Nagai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
Thomas E. Sussan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Synthetic Triterpenoids Attenuate Cytotoxic Retinal Injury: Cross-talk between Nrf2 and PI3K/AKT Signaling through Inhibition of the Lipid Phosphatase PTEN
Ian Pitha-Rowe et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Down-Regulated NF-E2-Related Factor 2 in Pulmonary Macrophages of Aged Smokers and Patients with Chronic Obstructive Pulmonary Disease
Masaru Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Mechanisms involved in A2E oxidation
So Ra Kim et al.
EXPERIMENTAL EYE RESEARCH (2008)
Oxidative damage-induced inflammation initiates age-related macular degeneration
Joe G. Hollyfield et al.
NATURE MEDICINE (2008)
Different electrostatic Potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
Kit I. Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Karen T. Liby et al.
NATURE REVIEWS CANCER (2007)
Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity
H Okawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
BTB protein keap1 targets antioxidant transcription factor nrf2 for ubiquitination by the cullin 3-Roc1 ligase
M Furukawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration
RA Radu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate for proteasomal degradation of Nrf2
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A2E-epoxides damage DNA in retinal pigment epithelial cells - Vitamin E and other antioxidants inhibit A2E-epoxide formation
JR Sparrow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles
K Itoh et al.
GENES TO CELLS (2003)
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
N Wakabayashi et al.
NATURE GENETICS (2003)
Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
JW Crabb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
